{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:48:49Z","timestamp":1793393329275,"version":"4.5.0"},"reference-count":55,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2019,3,25]]},"DOI":"10.1167\/iovs.18-24743","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T16:30:41Z","timestamp":1553531441000},"page":"1156","source":"Crossref","is-referenced-by-count":25,"title":["Bromfenac Inhibits TGF-\u03b21\u2013Induced Fibrotic Effects in Human Pterygium and Conjunctival Fibroblasts"],"prefix":"10.1167","volume":"60","author":[{"given":"Kailin","family":"Chen","sequence":"first","affiliation":[{"name":"Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China"},{"name":"Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kairan","family":"Lai","sequence":"additional","affiliation":[{"name":"Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China"},{"name":"Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China"},{"name":"Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Qin","sequence":"additional","affiliation":[{"name":"Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China"},{"name":"Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Fu","sequence":"additional","affiliation":[{"name":"Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China"},{"name":"Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenqi","family":"Luo","sequence":"additional","affiliation":[{"name":"Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China"},{"name":"Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuming","family":"Jin","sequence":"additional","affiliation":[{"name":"Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China"},{"name":"Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Hu","sequence":"additional","affiliation":[{"name":"Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China"},{"name":"Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China"},{"name":"Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yao","sequence":"additional","affiliation":[{"name":"Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China"},{"name":"Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-60-4-1156-b01","doi-asserted-by":"crossref","unstructured":"Liu T, Liu Y, Xie L, He X, Bai J. Progress in the pathogenesis of pterygium. Curr Eye Res. 2013; 38: 1191\u20131197.","DOI":"10.3109\/02713683.2013.823212"},{"key":"i1552-5783-60-4-1156-b02","doi-asserted-by":"crossref","unstructured":"Mackenzie FD, Hirst LW, Battistutta D, Green A. Risk analysis in the development of pterygia. Ophthalmology. 1992; 99: 1056\u20131061.","DOI":"10.1016\/S0161-6420(92)31850-0"},{"key":"i1552-5783-60-4-1156-b03","doi-asserted-by":"crossref","unstructured":"Kim KW, Park SH, Kim JC. Fibroblast biology in pterygia. Exp Eye Res. 2016; 142: 32\u201339.","DOI":"10.1016\/j.exer.2015.01.010"},{"key":"i1552-5783-60-4-1156-b04","doi-asserted-by":"crossref","unstructured":"Seet LF, Tong L, Su R, Wong TT. Involvement of SPARC and MMP-3 in the pathogenesis of human pterygium. Invest Ophthalmol Vis Sci. 2012; 53: 587\u2013595.","DOI":"10.1167\/iovs.11-7941"},{"key":"i1552-5783-60-4-1156-b05","doi-asserted-by":"crossref","unstructured":"Ang LP, Chua JL, Tan DT. Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol. 2007; 18: 308\u2013313.","DOI":"10.1097\/ICU.0b013e3281a7ecbb"},{"key":"i1552-5783-60-4-1156-b06","doi-asserted-by":"crossref","unstructured":"Mearza AA, Aslanides IM. Uses and complications of mitomycin C in ophthalmology. Expert Opin Drug Saf. 2007; 6: 27\u201332.","DOI":"10.1517\/14740338.6.1.27"},{"key":"i1552-5783-60-4-1156-b07","doi-asserted-by":"crossref","unstructured":"Sheppard JD, Mansur A, Comstock TL, Hovanesian JA. An update on the surgical management of pterygium and the role of loteprednol etabonate ointment. Clin Ophthalmol. 2014; 8: 1105\u20131118.","DOI":"10.2147\/OPTH.S55259"},{"key":"i1552-5783-60-4-1156-b08","doi-asserted-by":"crossref","unstructured":"Prabhasawat P, Tesavibul N, Leelapatranura K, Phonjan T. Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium. Ophthalmology. 2006; 113: 1102\u20131109.","DOI":"10.1016\/j.ophtha.2006.02.026"},{"key":"i1552-5783-60-4-1156-b09","doi-asserted-by":"crossref","unstructured":"Kheirkhah A, Nazari R, Safi H, Ghassemi H, Behrouz MJ, Raju VK. Effects of intraoperative steroid injection on the outcome of pterygium surgery. Eye (Lond). 2013; 27: 906\u2013914.","DOI":"10.1038\/eye.2013.142"},{"key":"i1552-5783-60-4-1156-b10","unstructured":"Jones R III, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol. 2006; 17: 163\u2013167."},{"key":"i1552-5783-60-4-1156-b11","doi-asserted-by":"crossref","unstructured":"Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013; 229: 298\u2013309.","DOI":"10.1002\/path.4104"},{"key":"i1552-5783-60-4-1156-b12","unstructured":"Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol. 1994; 145: 114\u2013125."},{"key":"i1552-5783-60-4-1156-b13","doi-asserted-by":"crossref","unstructured":"Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012; 18: 1028\u20131040.","DOI":"10.1038\/nm.2807"},{"key":"i1552-5783-60-4-1156-b14","unstructured":"Nakamura K, Kurosaka D, Yoshino M, Oshima T, Kurosaka H. Injured corneal epithelial cells promote myodifferentiation of corneal fibroblasts. Invest Ophthalmol Vis Sci. 2002; 43: 2603\u20132608."},{"key":"i1552-5783-60-4-1156-b15","doi-asserted-by":"crossref","unstructured":"Saika S. TGFbeta pathobiology in the eye. Lab Invest. 2006; 86: 106\u2013115.","DOI":"10.1038\/labinvest.3700375"},{"key":"i1552-5783-60-4-1156-b16","doi-asserted-by":"crossref","unstructured":"Nuwormegbe SA, Sohn JH, Kim SW. A PPAR-gamma agonist rosiglitazone suppresses fibrotic response in human pterygium fibroblasts by modulating the p38 MAPK pathway. Invest Ophthalmol Vis Sci. 2017; 58: 5217\u20135226.","DOI":"10.1167\/iovs.17-22203"},{"key":"i1552-5783-60-4-1156-b17","doi-asserted-by":"crossref","unstructured":"Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res. 2004; 23: 195\u2013228.","DOI":"10.1016\/j.preteyeres.2004.02.002"},{"key":"i1552-5783-60-4-1156-b18","doi-asserted-by":"crossref","unstructured":"Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem. 1996; 98: 195\u2013201.","DOI":"10.1016\/S0065-1281(96)80038-9"},{"key":"i1552-5783-60-4-1156-b19","doi-asserted-by":"crossref","unstructured":"Bianchi E, Scarinci F, Grande C, et al. Immunohistochemical profile of VEGF, TGF-beta and PGE(2) in human pterygium and normal conjunctiva: experimental study and review of the literature. Int J Immunopathol Pharmacol. 2012; 25: 607\u2013615.","DOI":"10.1177\/039463201202500307"},{"key":"i1552-5783-60-4-1156-b20","doi-asserted-by":"crossref","unstructured":"Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol. 1998; 236: 702\u2013708.","DOI":"10.1007\/s004170050144"},{"key":"i1552-5783-60-4-1156-b21","doi-asserted-by":"crossref","unstructured":"Zhang J, Tian XJ, Xing J. Signal transduction pathways of EMT induced by TGF-beta, SHH, and WNT and their crosstalks. J Clin Med. 2016; 5: E41.","DOI":"10.3390\/jcm5040041"},{"key":"i1552-5783-60-4-1156-b22","doi-asserted-by":"crossref","unstructured":"Hugo HJ, Saunders C, Ramsay RG, Thompson EW. New Insights on COX-2 in chronic inflammation driving breast cancer growth and metastasis. J Mammary Gland Biol Neoplasia. 2015; 20: 109\u2013119.","DOI":"10.1007\/s10911-015-9333-4"},{"key":"i1552-5783-60-4-1156-b23","doi-asserted-by":"crossref","unstructured":"Chaudhary SC, Singh T, Kapur P, et al. Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis. Toxicol Appl Pharmacol. 2013; 268: 249\u2013255.","DOI":"10.1016\/j.taap.2012.12.009"},{"key":"i1552-5783-60-4-1156-b24","unstructured":"Chiang CC, Cheng YW, Lin CL, et al. Cyclooxygenase 2 expression in pterygium. Mol Vis. 2007; 13: 635\u2013638."},{"key":"i1552-5783-60-4-1156-b25","unstructured":"Gao Y, Zhang MC, Peng Y. Expression of cyclooxygenase-2 in pterygium and effects of selective cyclooxygenase-2 inhibitor on human pterygium fibroblasts [in Chinese]. Zhonghua Yan Ke Za Zhi. 2007; 43: 881\u2013884."},{"key":"i1552-5783-60-4-1156-b26","doi-asserted-by":"crossref","unstructured":"Ozcimen M, Sakarya Y, Goktas S, et al. Effect of nepafenac eye drops on pain associated with pterygium surgery. Eye Contact Lens. 2015; 41: 187\u2013189.","DOI":"10.1097\/ICL.0000000000000107"},{"key":"i1552-5783-60-4-1156-b27","doi-asserted-by":"crossref","unstructured":"Sheppard JD. Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review. Clin Ophthalmol. 2016; 10: 2099\u20132111.","DOI":"10.2147\/OPTH.S86971"},{"key":"i1552-5783-60-4-1156-b28","doi-asserted-by":"crossref","unstructured":"Lim BX, Lim CH, Lim DK, Evans JR, Bunce C, Wormald R. Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. Cochrane Database Syst Rev. 2016; 11: Cd006683.","DOI":"10.1002\/14651858.CD006683.pub3"},{"key":"i1552-5783-60-4-1156-b29","doi-asserted-by":"crossref","unstructured":"Aptel F, Colin C, Kaderli S, Deloche C, Bron AM. Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey. Br J Ophthalmol. 2017; 101: 1\u201310.","DOI":"10.1136\/bjophthalmol-2017-310324"},{"key":"i1552-5783-60-4-1156-b30","doi-asserted-by":"crossref","unstructured":"Lee JS, Kim YH. The toxicity of nonsteroidal anti-inflammatory eye drops against human corneal epithelial cells in vitro. J Korean Med Sci. 2015; 30: 1856\u20131864.","DOI":"10.3346\/jkms.2015.30.12.1856"},{"key":"i1552-5783-60-4-1156-b31","doi-asserted-by":"crossref","unstructured":"Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997; 115: 1235\u20131240.","DOI":"10.1001\/archopht.1997.01100160405001"},{"key":"i1552-5783-60-4-1156-b32","doi-asserted-by":"crossref","unstructured":"Durkin SR, Abhary S, Newland HS, Selva D, Aung T, Casson RJ. The prevalence, severity and risk factors for pterygium in central Myanmar: the Meiktila Eye Study. Br J Ophthalmol. 2008; 92: 25\u201329.","DOI":"10.1136\/bjo.2007.119842"},{"key":"i1552-5783-60-4-1156-b33","unstructured":"Qu M, Wang Y, Yang L, Zhou Q. Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells: independent in active components. Mol Vis. 2011; 17: 3147\u20133155."},{"key":"i1552-5783-60-4-1156-b34","doi-asserted-by":"crossref","unstructured":"Han S, Chen Y, Gao Y, Sun B, Kong Y. MicroRNA-218\u20135p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K\/Akt\/mTOR signaling pathway. Exp Eye Res. 2018; 178: 37\u201345.","DOI":"10.1016\/j.exer.2018.09.010"},{"key":"i1552-5783-60-4-1156-b35","doi-asserted-by":"crossref","unstructured":"Wu CW, Peng ML, Yeh KT, Tsai YY, Chiang CC, Cheng YW. Inactivation of p53 in pterygium influence miR-200a expression resulting in ZEB1\/ZEB2 up-regulation and EMT processing. Exp Eye Res. 2016; 146: 206\u2013211.","DOI":"10.1016\/j.exer.2016.03.012"},{"key":"i1552-5783-60-4-1156-b36","doi-asserted-by":"crossref","unstructured":"Tsai YY, Chiang CC, Yeh KT, Lee H, Cheng YW. Effect of TIMP-1 and MMP in pterygium invasion. Invest Ophthalmol Vis Sci. 2010; 51: 3462\u20133467.","DOI":"10.1167\/iovs.09-4921"},{"key":"i1552-5783-60-4-1156-b37","doi-asserted-by":"crossref","unstructured":"Di Girolamo N, Tedla N, Kumar RK, et al. Culture and characterisation of epithelial cells from human pterygia. Br J Ophthalmol. 1999; 83: 1077\u20131082.","DOI":"10.1136\/bjo.83.9.1077"},{"key":"i1552-5783-60-4-1156-b38","doi-asserted-by":"crossref","unstructured":"Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res. 1999; 250: 273\u2013283.","DOI":"10.1006\/excr.1999.4543"},{"key":"i1552-5783-60-4-1156-b39","doi-asserted-by":"crossref","unstructured":"Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell. 2001; 12: 2730\u20132741.","DOI":"10.1091\/mbc.12.9.2730"},{"key":"i1552-5783-60-4-1156-b40","doi-asserted-by":"crossref","unstructured":"Xu YX, Zhang LY, Zou DL, et al. Differential expression and function of survivin during the progress of pterygium. Invest Ophthalmol Vis Sci. 2014; 55: 8480\u20138487.","DOI":"10.1167\/iovs.14-15715"},{"key":"i1552-5783-60-4-1156-b41","doi-asserted-by":"crossref","unstructured":"Kaidanovich-Beilin O, Woodgett JR. GSK-3: functional insights from cell biology and animal models. Front Mol Neurosci. 2011; 4: 40.","DOI":"10.3389\/fnmol.2011.00040"},{"key":"i1552-5783-60-4-1156-b42","doi-asserted-by":"crossref","unstructured":"Zhang PP, Wang PQ, Qiao CP, et al. Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT\/GSK-3beta\/beta-catenin axis and TGF-beta induced EMT with sophocarpine. Cancer Lett. 2016; 376: 95\u2013103.","DOI":"10.1016\/j.canlet.2016.01.011"},{"key":"i1552-5783-60-4-1156-b43","doi-asserted-by":"crossref","unstructured":"Park NR, Cha JH, Jang JW, et al. Synergistic effects of CD44 and TGF-beta1 through AKT\/GSK-3beta\/beta-catenin signaling during epithelial-mesenchymal transition in liver cancer cells. Biochem Biophys Res Commun. 2016; 477: 568\u2013574.","DOI":"10.1016\/j.bbrc.2016.06.077"},{"key":"i1552-5783-60-4-1156-b44","doi-asserted-by":"crossref","unstructured":"Caraci F, Gili E, Calafiore M, et al. TGF-beta1 targets the GSK-3beta\/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res. 2008; 57: 274\u2013282.","DOI":"10.1016\/j.phrs.2008.02.001"},{"key":"i1552-5783-60-4-1156-b45","doi-asserted-by":"crossref","unstructured":"Medici D, Potenta S, Kalluri R. Transforming growth factor-beta2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem J. 2011; 437: 515\u2013520.","DOI":"10.1042\/BJ20101500"},{"key":"i1552-5783-60-4-1156-b46","doi-asserted-by":"crossref","unstructured":"Yu L, Wu WK, Li ZJ, et al. E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase\/activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma. J Pharmacol Exp Ther. 2008; 327: 258\u2013267.","DOI":"10.1124\/jpet.108.141275"},{"key":"i1552-5783-60-4-1156-b47","doi-asserted-by":"crossref","unstructured":"Yu L, Wu WK, Li ZJ, Li HT, Wu YC, Cho CH. Prostaglandin E(2) promotes cell proliferation via protein kinase C\/extracellular signal regulated kinase pathway-dependent induction of c-Myc expression in human esophageal squamous cell carcinoma cells. Int J Cancer. 2009; 125: 2540\u20132546.","DOI":"10.1002\/ijc.24607"},{"key":"i1552-5783-60-4-1156-b48","doi-asserted-by":"crossref","unstructured":"Buchanan FG, Wang D, Bargiacchi F, DuBois RN. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem. 2003; 278: 35451\u201335457.","DOI":"10.1074\/jbc.M302474200"},{"key":"i1552-5783-60-4-1156-b49","doi-asserted-by":"crossref","unstructured":"Fujino H, West KA, Regan JW. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem. 2002; 277: 2614\u20132619.","DOI":"10.1074\/jbc.M109440200"},{"key":"i1552-5783-60-4-1156-b50","doi-asserted-by":"crossref","unstructured":"Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science. 2005; 310: 1504\u20131510.","DOI":"10.1126\/science.1116221"},{"key":"i1552-5783-60-4-1156-b51","doi-asserted-by":"crossref","unstructured":"Guo Y, Gupte M, Umbarkar P, et al. Entanglement of GSK-3beta, beta-catenin and TGF-beta1 signaling network to regulate myocardial fibrosis. J Mol Cell Cardiol. 2017; 110: 109\u2013120.","DOI":"10.1016\/j.yjmcc.2017.07.011"},{"key":"i1552-5783-60-4-1156-b52","doi-asserted-by":"crossref","unstructured":"Lam AP, Gottardi CJ. Beta-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol. 2011; 23: 562\u2013567.","DOI":"10.1097\/BOR.0b013e32834b3309"},{"key":"i1552-5783-60-4-1156-b53","doi-asserted-by":"crossref","unstructured":"Akhmetshina A, Palumbo K, Dees C, et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun. 2012; 3: 735.","DOI":"10.1038\/ncomms1734"},{"key":"i1552-5783-60-4-1156-b54","doi-asserted-by":"crossref","unstructured":"Poon R, Nik SA, Ahn J, Slade L, Alman BA. Beta-catenin and transforming growth factor beta have distinct roles regulating fibroblast cell motility and the induction of collagen lattice contraction. BMC Cell Biol. 2009; 10: 38.","DOI":"10.1186\/1471-2121-10-38"},{"key":"i1552-5783-60-4-1156-b55","doi-asserted-by":"crossref","unstructured":"Padala RR, Karnawat R, Viswanathan SB, Thakkar AV, Das AB. Cancerous perturbations within the ERK, PI3K\/Akt, and Wnt\/beta-catenin signaling network constitutively activate inter-pathway positive feedback loops. Mol Biosyst. 2017; 13: 830\u2013840.","DOI":"10.1039\/C6MB00786D"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2729330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:02Z","timestamp":1791927062000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24743","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,25]]}}}